1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Human Microbiome Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Human Microbiome Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Human Microbiome Market - Breakup by Product
6.1 Probiotics
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Prebiotics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.3 Diagnostic Tests
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
6.4 Drugs
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Forecast (2024-2032)
6.5 Medical Food
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2018-2023)
6.5.3 Market Forecast (2024-2032)
6.6 Others
6.6.1 Historical and Current Market Trends (2018-2023)
6.6.2 Market Forecast (2024-2032)
7 United States Human Microbiome Market - Breakup by Application
7.1 Therapeutics
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Diagnostics
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
8 United States Human Microbiome Market - Breakup by Disease Type
8.1 Obesity
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Diabetes
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Autoimmune Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Cancer
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Forecast (2024-2032)
8.5 Gastrointestinal Disorders
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Forecast (2024-2032)
8.6 Central Nervous System Disorders
8.6.1 Overview
8.6.2 Historical and Current Market Trends (2018-2023)
8.6.3 Market Forecast (2024-2032)
8.7 Others
8.7.1 Historical and Current Market Trends (2018-2023)
8.7.2 Market Forecast (2024-2032)
9 United States Human Microbiome Market – Breakup by Region
9.1 Northeast
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Breakup by Product
9.1.4 Market Breakup by Application
9.1.5 Market Breakup by Disease Type
9.1.6 Key Players
9.1.7 Market Forecast (2024-2032)
9.2 Midwest
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Breakup by Product
9.2.4 Market Breakup by Application
9.2.5 Market Breakup by Disease Type
9.2.6 Key Players
9.2.7 Market Forecast (2024-2032)
9.3 South
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Breakup by Product
9.3.4 Market Breakup by Application
9.3.5 Market Breakup by Disease Type
9.3.6 Key Players
9.3.7 Market Forecast (2024-2032)
9.4 West
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2018-2023)
9.4.3 Market Breakup by Product
9.4.4 Market Breakup by Application
9.4.5 Market Breakup by Disease Type
9.4.6 Key Players
9.4.7 Market Forecast (2024-2032)
10 United States Human Microbiome Market – Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant
11 Profiles of Key Players
11.1 Company A
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 Company B
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 Company C
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Company D
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Company E
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
12 United States Human Microbiome Market - Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 Appendix